Clinical Trials on Carbohydrate Metabolism Disorder

Total 162044 results

Rocket Pharmaceuticals Inc.

Recruiting

Danon Disease Natural History Study

Danon Disease

United States, Germany
University of California, San Diego
Rocket Pharmaceuticals Inc.

Recruiting

The Natural History of Danon Disease

Danon Disease

United States
Alnylam Pharmaceuticals

Completed

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1

Primary Hyperoxaluria | PH1 | RNAi Therapeutic | siRNA | AGT

France, United Kingdom, Netherlands, Israel, Germany
Genzyme, a Sanofi Company
BioMarin/Genzyme LLC

Terminated

A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants

Mucopolysaccharidosis I | Hurler's Syndrome | Hurler-Scheie Syndrome | Scheie

Italy
Dr. Prayuth Sudathip
Medicines for Malaria Venture

Completed

Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure After G6PD Testing in Thailand (ARCTIC)

Malaria, Vivax | G6PD Deficiency

Thailand
BioMarin Pharmaceutical

Terminated

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

Morquio A Syndrome | MPS IVA | Mucopolysaccharidosis IVA

United States, United Kingdom, Canada, Germany
Genzyme, a Sanofi Company
BioMarin/Genzyme LLC

Completed

Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients

Mucopolysaccharidosis I | Scheie Syndrome | Hurler's Syndrome | Hurler-Scheie Syndrome

United States, Canada, United Kingdom, Brazil, Germany, Italy, Netherlands
Genzyme, a Sanofi Company
BioMarin/Genzyme LLC

Completed

A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease

Mucopolysaccharidosis I | Scheie Syndrome | Hurler's Syndrome | Hurler-Scheie Syndrome

Brazil, Canada
Patricia I. Dickson, M.D.
University of California, Los Angeles; FDA Office of Orphan Products Development and other collaborators

Terminated

Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I

Mucopolysaccharidosis I | Lysosomal Storage Diseases | Spinal Cord Compression

United States, Finland
Zeltiq Aesthetics

Completed

Submental Study (Sequential Treatment Approach) (CMK)

Body Fat Disorder

United States
Zeltiq Aesthetics

Completed

DualSculpting the Abdomen Using CoolSculpting (DSA)

Body Fat Disorder

United States
Zeltiq Aesthetics

Completed

CoolSculpting in the Abdomen Using Applicator With and Without CCI (CCI)

Body Fat Disorder

United States
Zeltiq Aesthetics

Completed

CoolSculpting of the Distal Thigh Study (DST)

Body Fat Disorder

United States
Zeltiq Aesthetics

Completed

CoolSculpting the Upper Arm Study (ARM)

Body Fat Disorder

Canada
Allergan

Completed

CoolSculpting® the Upper Arms and Inner Thighs in Participants of Chinese Descent (XinCOOL)

Body Fat Disorder

Canada
Zeltiq Aesthetics

Unknown

CoolSculpting the Flanks (CSI)

Body Fat Disorder

United States
Zeltiq Aesthetics

Unknown

CoolSculpting System (ELI)

Body Fat Disorder

United States
Zeltiq Aesthetics

Withdrawn

Retrospective Study of Patient Surveys

Body Fat Disorder
Universidade Cidade de Sao Paulo
Universidade Federal de Sao Carlos

Completed

Cryolipolisis for Abdomen and Flank Fat Reduction

Subcutaneous Fat Disorder

Brazil
Zeltiq Aesthetics

Completed

A Pilot Clinical Trial Investigating the Effect of Cutaneous Cooling on Sebum Production

Body Fat Disorder

United States
Zeltiq Aesthetics

Completed

Pilot Study of CoolTXT for Non-Invasive Fat Reduction

Body Fat Disorder

Canada
Zeltiq Aesthetics

Completed

Extended Follow-Up Study for Subjects Who Participated in 2010 Study (JUNO)

Body Fat Disorder

United States
Medical University of Vienna

Recruiting

Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study. (POMPE)

Pompe Disease | McArdle Disease

Austria
Assistance Publique - Hôpitaux de Paris

Recruiting

Natural History of Pompe Disease (POMPE)

Glycogen Storage Disease Type II, Adult

France
BioMarin Pharmaceutical

Terminated

A Prospective, Noninterventional, Observational Study of Late-Onset Pompe Disease

Late-onset Pompe Patients Untreated or Treated With rhGAA

Spain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania
Assistance Publique - Hôpitaux de Paris
ITERG; Institut Elevage; SAINT HUBERT; TERRES UNIVIA; TERRES INOVIA

Completed

Dietary Intake of Alpha-linolenic Acid in Elderly

Cardiovascular Diseases | Inflammation | Metabolism Disorder, Lipid

France
Horizon Pharma USA, Inc.

Completed

Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease (MITO-001)

Inherited Mitochondrial Disease, Including Leigh Syndrome

United States
Genzyme, a Sanofi Company

Completed

Avalglucosidase Alfa Extension Study (NEO-EXT)

Glycogen Storage Disease Type II Pompe Disease

United States, Belgium, Denmark, France, Germany, Netherlands, United Kingdom
Genzyme, a Sanofi Company

Active, not recruiting

A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa (Mini-COMET)

Glycogen Storage Disease Type II-Pompe's Disease

United States, France, Japan, Taiwan, United Kingdom
BTL Industries Ltd.

Completed

Non-invasive Lipolysis and Improvement of Muscle Tone in Upper Arms

Fat Disorder

United States
BTL Industries Ltd.

Completed

Non-invasive Lipolysis and Improvement of Muscle Tone in Inner Thighs

Fat Disorder

United States
Great Ormond Street Hospital for Children NHS Foundation...
National Institute for Health Research, United Kingdom; The Freya Foundation

Recruiting

Natural History Study of Pyruvate Dehydrogenase Deficiency

Pyruvate Dehydrogenase Complex Deficiency | Pyruvate Dehydrogenase E1 Alpha Deficiency | Pyruvate Dehydrogenase E1-Beta Deficiency | Pyruvate Dehydrogenase E2 Deficiency | Pyruvate Dehydrogenase Phosphatase Deficiency

United Kingdom
Zeltiq Aesthetics

Completed

Fat Layer Reduction in the Lateral Thighs Using CoolSculpting

Body Fat Disorder

United States
Zeltiq Aesthetics

Completed

Fat Reduction in the Submandibular/Submental Area

Body Fat Disorder

United States
Zeltiq Aesthetics

Completed

CoolSculpting Treatment in the Upper Arms (ARM)

Body Fat Disorder

Canada
Zeltiq Aesthetics

Completed

Multiple CoolSculpting Treatment Study

Body Fat Disorder

United States
Zeltiq Aesthetics

Completed

Bilateral; Flank Study With Crown Cooling Insert (CCI)

Body Fat Disorder

United States
Zeltiq Aesthetics

Completed

Feasibility Study of a Belt Applicator

Body Fat Disorder

United States
Zeltiq Aesthetics

Completed

Non-Invasive Reduction of Fat in the Flanks of Patients With Sharp Body Curvature

Body Fat Disorder

United States
Zeltiq Aesthetics

Completed

CoolSculpting and EMS for the Abdomen (ECA)

Body Fat Disorder

United States
Zeltiq Aesthetics

Completed

Outer Thigh Study With Varied Treatment Parameters

Body Fat Disorder

United States
Zeltiq Aesthetics

Completed

Pilot Study on the Submental Area

Body Fat Disorder

United States
University of Padova

Completed

Short-term Cocoa Supplementation and Elite Soccer Players (COCOA)

Dyslipidemias | Fatty Acid; Metabolic Disorder

Italy
Shire

Completed

Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094

Hunter Syndrome

United States, Spain, Canada, United Kingdom, Mexico, Australia, France
Green Cross Corporation

Completed

A Study of GC1111 in Hunter Syndrom Patients

Hunter Syndrome

Korea, Republic of
Lundquist Institute for Biomedical Innovation at...

Active, not recruiting

Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI

Mucopolysaccharidosis I | Mucopolysaccharidosis II | Mucopolysaccharidosis VI

United States
Shire

Completed

Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®

Hunter Syndrome

United States, United Kingdom
Green Cross Corporation

Unknown

The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients

Hunter Syndrome

Korea, Republic of
Kantonsspital Baden

Completed

Cold Induced Futile Cycles In White Adipose Tissue (Metabol)

Metabolism Disorder

Switzerland
University of Seville
Spanish National Research Council

Active, not recruiting

Lipoproteins and ImmunoMetabolism

Inflammation | Obesity | Metabolic Syndrome | Immune System and Related Disorders | Metabolism Disorder

Spain

Clinical Trials on Carbohydrate Metabolism Disorder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations